Healthcare Analytical Testing Services Market Size, Share, and Trends 2024 to 2034

Chapter 1. Introduction

1.1. Research Objective    
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis

Chapter 5. COVID-19 Impact on Healthcare Analytical Testing Services Market

5.1. COVID-19 Landscape: Healthcare Analytical Testing Services Industry Impact
5.2. COVID-19  Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers

Chapter 8. Global Healthcare Analytical Testing Services Market, By Type

8.1. Healthcare Analytical Testing Services Market, by Type Type
8.1.1. Medical Device Analytical Testing Services
8.1.1.1. Market Revenue and Forecast 
8.1.2. Pharmaceutical Analytical Testing Services
8.1.2.1. Market Revenue and Forecast

Chapter 9. Global Healthcare Analytical Testing Services Market, Regional Estimates and Trend Forecast

9.1. North America
9.1.1. Market Revenue and Forecast, by Type 
9.1.2. U.S.
9.1.2.1. Market Revenue and Forecast, by Type 
9.1.3. Rest of North America
9.1.3.1. Market Revenue and Forecast, by Type 
9.2. Europe
9.2.1. Market Revenue and Forecast, by Type 
9.2.2. UK
9.2.2.1. Market Revenue and Forecast, by Type 
9.2.3. Germany
9.2.3.1. Market Revenue and Forecast, by Type 
9.2.4. France
9.2.4.1. Market Revenue and Forecast, by Type 
9.2.5. Rest of Europe
9.2.5.1. Market Revenue and Forecast, by Type 
9.3. APAC
9.3.1. Market Revenue and Forecast, by Type 
9.3.2. India
9.3.2.1. Market Revenue and Forecast, by Type 
9.3.3. China
9.3.3.1. Market Revenue and Forecast, by Type 
9.3.4. Japan
9.3.4.1. Market Revenue and Forecast, by Type 
9.3.5. Rest of APAC
9.3.5.1. Market Revenue and Forecast, by Type 
9.4. MEA
9.4.1. Market Revenue and Forecast, by Type 
9.4.2. GCC
9.4.2.1. Market Revenue and Forecast, by Type 
9.4.3. North Africa
9.4.3.1. Market Revenue and Forecast, by Type 
9.4.4. South Africa
9.4.4.1. Market Revenue and Forecast, by Type 
9.4.5. Rest of MEA
9.4.5.1. Market Revenue and Forecast, by Type 
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Type 
9.5.2. Brazil
9.5.2.1. Market Revenue and Forecast, by Type 
9.5.3. Rest of LATAM
9.5.3.1. Market Revenue and Forecast, by Type

Chapter 10. Company Profiles

10.1. Thermo Fisher Scientific, Inc.
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. ICON plc
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. LabCorp
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Charles River Laboratories International, Inc.
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Toxikon, Inc.
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Intertek Group
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Eurofins Scientific
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Pace Analytical Services, LLC 
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Syneos Health
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. SGS SA
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives

Chapter 11. Research Methodology

11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions

Chapter 12. Appendix

12.1. About Us
12.2. Glossary of Terms